IV Medication Administration: Bolus, Piggyback and Infusions

IV medication errors are fast and often silent. Check every drug, push at the labeled rate, and flush before and after each dose.

IV medication administration puts a drug into the bloodstream through a catheter that is already in place. Three forms are in common use. A push is a measured bolus by syringe. A piggyback is an intermittent bag on a secondary set. A continuous infusion is a bag or syringe run on a pump. Each form has its own rate, dilution and monitoring rules. The drug label and local protocol set them. Catheter placement is covered on the IV insertion page.

How It Works

• Push: one dose, delivered over seconds to minutes. Rate is the control here. It limits the peak effect and many adverse effects.
• Piggyback: a secondary bag joins the primary line at a Y-site, close to the catheter. It runs for a set time.
• Infusion: the pump holds a set rate in mL/hr. That is how you titrate vasoactive, sedative and antiarrhythmic agents.
• Volume and concentration: dilution sets the rate and the amount per mL. Get the concentration wrong and you have made a dose error.

Where It Fits

Confirm the line is patent and the site is clear first. Then give the drug, and not before. If IV access fails and the patient needs drugs now, the protocol may call for intraosseous access (see Intraosseous Access). Drip-rate arithmetic for gravity sets is in the infusion calculations reference.

Indications

• A drug ordered or protocol-directed by the IV route, as a push, a piggyback or a continuous infusion
• A drug whose labeled route is IV and that needs fast onset
• Titrated therapy that needs a pump and a continuous rate

Absolute Contraindications

• A product not labeled for IV use, or a drug whose label restricts it to another route (check the label)
• Undiluted potassium chloride concentrate, or any potassium product given as a push
• An unverified drug, concentration or dose: stop and clarify the order before giving anything

Relative Contraindications & Cautions

• A site with infiltration, phlebitis, burn or infection: choose another site or route
• A vesicant or osmotic drug through a peripheral line: confirm the site and the protocol before starting
• Hypotension, bradycardia, arrhythmia or sedation: slow the rate and reassess before the next dose
• An arm with an AV fistula or graft: do not use it (see the IV insertion page)

Consider an Alternative

• Intraosseous access when IV access fails or is impractical (Intraosseous Access)
• A different route when the label allows it and the clinical need is not immediate; confirm with the order

Team Roles During the Procedure

• Medication clinician: draws up, labels and gives the drug
• Checker: verifies drug, concentration, dose, rate and patient independently
• Monitor: watches rhythm, blood pressure, SpO₂ and the site during and after the dose
• Recorder: documents drug, dose, route, rate, time and response

Medication Checks

• Identity and order: patient identifiers, drug name on the label, and the order or protocol step
• Dose and concentration: dose in mg and mL, the concentration, and the weight used for weight-based doses
• Route and rate: IV route on the label, the labeled push time or the pump rate
• Compatibility and timing: compatible diluent, any Y-site partner, and the time of the last dose of the same drug

Read the label at the bedside. Not from memory. Where a drug comes in more than one strength, say the strength out loud before you draw up.

Physiologic Risk

Get a baseline before any sedative, opioid, antiarrhythmic or vasoactive drug: blood pressure, heart rate, rhythm, SpO₂ and level of consciousness. Hypotension, bradycardia and respiratory depression change how fast a push can safely go. Hold or slow the drug, then reassess per protocol.

Site / Device Check

• Flush the line: free flow with no resistance
• Look at the site: no swelling, pain, coolness or blanching
• Check the catheter and set dates, and the dressing

Equipment

Sizing

Find the weight in kilograms on the order before you touch the calculator. Weight-based drugs cannot be dosed without that number. Pediatric equipment sizes are on the equipment sizing page. Weight-based dosing is on the weight-based dosing page.

These doses are typical adult and pediatric references. Check them against local protocol and the current drug label. Doses vary by protocol; follow local protocols and medical direction.

Push rates for other common IV drugs live on their medication pages. That includes lorazepam, ondansetron, diazepam, midazolam and amiodarone. Check the label on each page before you give the drug.

Piggyback (Secondary) Infusions

• Y-site compatibility: check each drug pair with a current institutional compatibility reference before connecting
• Order and timing: follow the order or protocol on whether the primary is paused, stopped or kept running during the piggyback
• Set changes: continuous secondary sets change no more often than every 96 hours and at least every 7 days (CDC 2011 guideline, Category IA). Intermittent sets: CDC gives no interval; follow agency policy. Blood, blood products and fat emulsions: within 24 hours. Propofol tubing: every 6 or 12 hours
• Flush: flush the secondary line before and after the drug, per agency policy

Continuous Infusions and Pump Programming

• Calculate first: convert the order into the pump rate in mL/hr. Say whether the rate is weight-based (mcg/kg/min, for example)
• Program and check: enter the drug, concentration, rate and volume, then compare the screen with the order before you start
• Use the drug library and limits: where the pump has a drug library, select the drug. Its dose limits then flag out-of-range entries.
• Gravity sets: drops per minute = mL per hour × drop factor ÷ 60. Use the drop factor printed on the set package
• Verify every rate change: a second person checks the new rate, and the change is recorded

Phase 1: Prepare

1. Confirm the order and the patient: identity, drug, dose, route, rate and indication match the order or protocol.
2. Read the label: confirm the strength, the diluent, the IV route, any rate limit and any boxed warning.
3. Calculate and draw up: state the dose in mg and mL and the weight used. Label the syringe or bag at the bedside.
4. Get the second check: for high-alert drugs, a second clinician verifies drug, dose, concentration and rate.

Phase 2: Perform

5. Check the line and site: free flow, and no swelling, pain or coolness.
6. Flush the line: a saline flush confirms patency before the drug.
7. Give the push at the labeled rate: push over the labeled time. Watch the site and the patient during the push; stop for pain, swelling, flushing, hypotension or a new arrhythmia.

8. Flush after the drug: give the saline flush the label or protocol requires, unless the label names another solution. Adenosine is followed by a rapid saline flush (label).
9. Start the piggyback or pump: connect the secondary at the Y-site after the compatibility check. Start the pump and confirm the screen matches the order.

Phase 3: Confirm & Monitor

10. Watch the site and the patient: check the site and vital signs at the times the drug and protocol require.
11. Document: drug, strength, dose, route, rate, start and stop times, pump settings, site, flushes and response.
12. Reassess at every move and handoff: confirm the pump, the rate, the site and the set dates.

Primary Confirmation

Before the drug, a saline flush runs freely and the site is clear. Through the push and the infusion, the site stays free of swelling, pain, coolness and blanching. The pump shows the programmed rate the whole time.

Secondary Confirmation

• Pump screen matches the order: drug, concentration, rate and volume remaining
• Patient response matches the expected effect of the drug, such as the rhythm after an antiarrhythmic
• The flush runs without resistance after each dose

Ongoing Monitoring

• During a push: site and patient continuously, with blood pressure and rhythm as the drug requires
• Continuous infusions: site, rate and volume at the interval your protocol sets, and at every move
• Set changes: record the date and time of each change; use the CDC schedule
• Sedatives and opioids: sedation score and respiratory rate per protocol

Pediatrics

• Weight-based: calculate every dose in mg/kg, check the adult maximum on the label, and have a second person verify
• Rates: pediatric labels often cap the rate in mg/kg/min or mg/min. The slower limit wins
• Concentration: pediatric volumes are small. One dilution error turns straight into a dose error. Write the concentration on the syringe
• Related pages: Weight-Based Dosing, Equipment Sizing, Vascular Access in Children

Pregnancy

• Check the label's pregnancy section for each drug before giving it. Adenosine label: use during pregnancy only if clearly needed
• Fosphenytoin: pregnancy lowers phenytoin levels. The label advises periodic serum concentration checks

Neonates

• The adenosine label dosed neonates by weight, the same as children. Calculate every dose in mg/kg and verify the concentration

Older Adults

• Start sedatives and antihypertensives at the low end of the label or protocol range, and check age-based dosing on the label
• Fragile veins and thin skin make infiltration more likely. Check the site more often

Renal and Hepatic Impairment

• Check the label for dose changes in renal or hepatic impairment before the dose
• Reduced clearance raises the risk of accumulation and of rate-related effects. Slow the rate and reassess

Dialysis Patients

• Do not give IV medications through, or place lines in, an arm with an AV fistula or graft (see the IV insertion page)

Physiologically Difficult

• Shock and low-flow states: slow the push, use the smallest effective volume, and check blood pressure before each dose
• Obesity: follow the label for the weight basis (total, ideal or lean) and the protocol for dosing

Immediate Aftercare

• Recheck the site, the flush and the pump settings after the dose
• Document the response and any change to the plan

Ongoing Maintenance

• Continuous administration sets, including secondary sets: no more often than every 96 hours and at least every 7 days, per the CDC 2011 guideline. Intermittent sets: follow agency policy, as CDC gives no interval
• Blood, blood products and fat emulsions: within 24 hours. Propofol tubing: every 6 or 12 hours, per the CDC 2011 guideline
• Needleless connectors: at least as often as the administration set; no benefit to changing more often than every 72 hours, per the CDC 2011 guideline
• Scrub each access port with an antiseptic before access

Transport Considerations

• Secure pumps and lines. Check for kinks and disconnections after every move
• Confirm pump power and battery before you leave
• Reassess the site and the rate after every move and handoff

Pearls

• Read the label each time: rates and maximums are drug-specific. They change from one label to the next
• Flush before and after: the flush confirms the line is open and clears the drug out of the catheter
• Rate is a safety control: many adverse effects come from giving the drug too fast. The fosphenytoin boxed warning shows exactly that
• Peripheral vasopressors: recent reviews report low risk of harm when vasopressors start peripherally. The site still needs close watch
• Vesicant patterns: acidic agents such as promethazine, amiodarone and vancomycin can cause edema, sloughing and necrosis. So can basic agents such as phenytoin and acyclovir

Common Pitfalls

• Pushing fast because the patient is crashing → push at the labeled rate. The drug's own limit wins
• A concentrate pushed as if it were diluted → read the concentration aloud and dilute every potassium dose
• A gravity set with the wrong drop factor → use the factor printed on that package
• A free flush taken as proof the drug is in the vein → check the site throughout
• An unchecked Y-site partner → check each pair before connecting

Skill Maintenance

• Practice IV pushes, piggyback set-up and pump programming in simulation, using a checklist
• Drill label reading and weight-based calculations at the frequency your agency requires
• Debrief medication errors and near misses with the same checklist
• Practice recognizing extravasation signs on a simulation arm or model